Vol. 43 No. 1 (2026): February
Statement

Recommendation of the Advisory Committee on Vaccines and Immunization Strategies-CAVEI on the use of the monoclonal antibody clesrovimab for passive immunization against respiratory syncytial virus in infants

Iván Ríos Orellana
Ministerio de Salud de Chile
Bio
Vivian Luchsinger
Facultad de Medicina, Universidad de Chile
Bio
Paula Leal
Hospital Dr. Exequiel González Cortés, Santiago
Carolina Ibañez
Facultad de Medicina, Universidad de Chile
Bio
Alejandra King
Hospital Dr. Luis Calvo Mackenna
Claudio Méndez
Facultad de Medicina, Universidad Austral de Chile.
Bio
Nicolás Faundes
Hospital Dr. Gustavo Fricke, Viña del Mar
Jaime Burrows
Hospital El Carmen de Maipú, Santiago
Josselin Novoa
Istituto de Saud Pública de Chile
José Crisóstomo
Instituto de Salud Pública de Chile
Adiela Saldaña
Instituto de Salud Pública de Chile
Jorge Vilches
Departamento de Epidemiología. Ministerio de Salud.
Elizabeth López
Departamento de Inmunizaciones. Ministerio de Salud.

Published 2026-01-20

How to Cite

1.
Ríos Orellana I, Luchsinger V, Leal P, Ibañez C, King A, Méndez C, Faundes N, Burrows J, Novoa J, Crisóstomo J, Saldaña A, Vilches J, López E. Recommendation of the Advisory Committee on Vaccines and Immunization Strategies-CAVEI on the use of the monoclonal antibody clesrovimab for passive immunization against respiratory syncytial virus in infants. Rev. Chilena. Infectol. [Internet]. 2026 Jan. 20 [cited 2026 Feb. 1];43(1). Available from: https://revinf.cl/index.php/revinf/article/view/2612